Similar articles

• Psoriasis associated with inflammatory bowel disease: a cross-sectional analysis in the NIH All of Us Research Program.

  Joel MZ, Wride AM, Cohen JM. Joel MZ, et al. Int J Dermatol. 2024 Mar;63(3):e82-e83. doi: 10.1111/ijd.17015. Epub 2024 Jan 10. Int J Dermatol. 2024. PMID: 38204174 No abstract available.
• Psoriasis associated with asthma and allergic rhinitis: a US-based cross-sectional study using the All of US Research Program.

  Joel MZ, Fan R, Damsky W, Cohen JM. Joel MZ, et al. Arch Dermatol Res. 2023 Aug;315(6):1823-1826. doi: 10.1007/s00403-023-02539-z. Epub 2023 Jan 28. Arch Dermatol Res. 2023. PMID: 36707438
• Concomitant Interstitial Lung Disease with Psoriasis.

  Ishikawa G, Dua S, Mathur A, Acquah SO, Salvatore M, Beasley MB, Padilla ML. Ishikawa G, et al. Can Respir J. 2019 Aug 25;2019:5919304. doi: 10.1155/2019/5919304. eCollection 2019. Can Respir J. 2019. PMID: 31534591 Free PMC article.
• Past achievements and future directions of sarcoidosis research: a NHLBI perspective.

  Reynolds HY, Peavy HH, Gail DB, Kiley JP. Reynolds HY, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2006 Jun;23(2):83-91. Sarcoidosis Vasc Diffuse Lung Dis. 2006. PMID: 17937103 Review.
• The risk of interstitial lung disease during biological treatment in Japanese patients with psoriasis.

  Matsumoto Y, Abe N, Tobita R, Kawakami H, Nakayama H, Setoguchi Y, Tsuboi R, Okubo Y. Matsumoto Y, et al. Clin Exp Dermatol. 2020 Oct;45(7):853-858. doi: 10.1111/ced.14259. Epub 2020 Jun 29. Clin Exp Dermatol. 2020. PMID: 32356612 Review.